Evidence map›Paper›PMID 39770698›Full record

ArticleMicroorganisms2024

Rice Kefiran Ameliorates Obesity and Hepatic Steatosis Through the Change in Gut Microbiota.

Takuto Kurakawa, Koudai Kani, Seita Chudan, Miyu Nishikawa, Yoshiaki Tabuchi, Kazuichi Sakamoto, Yoshinori Nagai, Shinichi Ikushiro, Yukihiro Furusawa

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Takuto KurakawaDepartment of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu 939-0398, Toyama, Japan.ORCID 0009-0005-0286-021X
Koudai KaniDepartment of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu 939-0398, Toyama, Japan.
Seita ChudanDepartment of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu 939-0398, Toyama, Japan.
Miyu NishikawaDepartment of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu 939-0398, Toyama, Japan.
Yoshiaki TabuchiDivision of Molecular Genetics Research, Life Science Research Center, University of Toyama, Sugitani, Toyama 930-0194, Toyama, Japan.ORCID 0000-0002-6007-6176
Kazuichi SakamotoCollege of Agriculture, Ibaraki University, 3-21-1. Chuo, Ami-cho, Ami-machi 300-0393, Ibaraki, Japan.
Yoshinori NagaiDepartment of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu 939-0398, Toyama, Japan.ORCID 0000-0002-5754-5357
Shinichi IkushiroDepartment of Biotechnology, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu 939-0398, Toyama, Japan.ORCID 0000-0001-5311-4069
Yukihiro FurusawaDepartment of Pharmaceutical Engineering, Faculty of Engineering, Toyama Prefectural University, 5180 Kurokawa, Imizu 939-0398, Toyama, Japan.ORCID 0000-0001-6020-6965

Funding

JSPS KAKENHI 20K05929LOTTE Foundation n/aTakeda Science Foundation n/aTojuro Iijima Foundation for Food Science and Technology n/a
6 · The paper itself

Abstract

Obesity is a global epidemic and a significant risk factor for various diseases. Obesity and dysbiosis are associated, drawing attention to the mechanisms that regulate the gut microbiota. In this study, we focused on the postbiotic effects of rice kefiran (Kef), a functional product of

Indexed as

AlistipesBacteroidesfatty liver diseasegut microbiotaobesityrice kefiran

Identifiers

PMID39770698
PMCPMC11728449

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.